focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYEW.L Regulatory News (YEW)

  • There is currently no data for YEW

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re Possible Cash Offer for Yew Grove REIT

17 Nov 2021 07:00

RNS Number : 6544S
Yew Grove REIT PLC
17 November 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

17 November 2021

UPDATE

in relation to

POSSIBLE CASH OFFER

for

YEW GROVE REIT PLC

Slate Office REIT ("Slate") has today issued a prospectus supplement (the "Prospectus Supplement") in respect of the bought deal offering by Slate for subscription receipts and convertible unsecured subordinated debentures previously announced by it in connection with the possible cash offer for Yew Grove REIT plc. ("Yew Grove") announced on 15 November 2021. A copy of the Prospectus Supplement can be accessed on the electronic filing system for the disclosure documents of issuers across Canada, SEDAR at www.sedar.com, filed under Slate Office REIT's Issuer Profile.

 

Enquiries:

IBI Corporate Finance (Financial Adviser to Slate) Tel: +353 1 963 1200

Tom Godfrey / Laurence O'Shaughnessy

Responsibility Statement

This announcement is issued on behalf of Slate Office REIT. Neither Yew Grove nor any of its directors, officers or employees owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person in connection with this announcement nor for the Prospectus Supplement referred to in this announcement.

The trustees of Slate accept responsibility for the information contained in this announcement. To the best of the knowledge and belief of the trustees of Slate (who have taken all reasonable care to ensure that this is the case) the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information.

IBI Corporate Finance Limited (trading as "IBI Corporate Finance") is acting exclusively as financial adviser to Slate and no one else in connection with the matters referred to in this Announcement and will not be responsible to anyone other than Slate for providing the protections afforded to its clients, or for providing advice in relation to the matters set out in this Announcement. Neither IBI Corporate Finance nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of IBI Corporate Finance in connection with this Announcement or any matter referred to herein.

Disclosure requirements of the Irish Takeover Rules

Under the provisions of Rule 8.3 of the Irish Takeover Rules, if any person is, or becomes, 'interested' (directly or indirectly) in, 1% or more of any class of 'relevant securities' of Yew Grove, all 'dealings' in any 'relevant securities' of Yew Grove (including by means of an option in respect of, or a derivative referenced to, any such 'relevant securities') must be publicly disclosed by not later than 3.30 pm (Irish time) on the 'business day' in Dublin following the date of the relevant transaction. This requirement will continue until the date on which the 'offer period' ends. If two or more persons co-operate on the basis of any agreement, either express or tacit, either oral or written, to acquire an 'interest' in 'relevant securities' of Yew Grove, they will be deemed to be a single person for the purpose of Rule 8.3 of the Irish Takeover Rules.

Under the provisions of Rule 8.1 of the Irish Takeover Rules, all 'dealings' in 'relevant securities' of Yew Grove by Slate, or by any party Acting in Concert with Slate, must also be disclosed by no later than 12:00 noon (Irish time) on the business day in Dublin following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose 'relevant securities' 'dealings' should be disclosed, can be found on the Irish Takeover Panel's website at www.irishtakeoverpanel.ie.

'Interests in securities' arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an 'interest' by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks are defined in the Irish Takeover Rules, which can also be found on the Irish Takeover Panel's website. If you are in any doubt as to whether or not you are required to disclose a dealing under Rule 8, please consult the Irish Takeover Panel's website at www.irishtakeoverpanel.ie or contact the Irish Takeover Panel on telephone number +353 1 678 9020.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGLBDBXGBDGBR
Date   Source Headline
30th Jun 20207:00 amRNSLTIP Option Awards / PDMR Notification
29th Jun 202012:24 pmRNSSecond Quarter Dividend
18th Jun 20204:49 pmRNSHolding(s) in Company
5th Jun 20207:00 amRNSRent Collection Update
29th May 20201:09 pmRNSResult of EGM
29th May 20201:02 pmRNSResult of AGM
19th May 202010:18 amRNSUpdate on upcoming General Meetings
28th Apr 202011:27 amRNSAnnual Report and Notice of AGM and EGM
24th Apr 20207:00 amRNSPublication of Annual Report
15th Apr 20207:00 amRNSTrading and Covid-19 Update & Dividend Declaration
6th Apr 20205:00 pmRNSHolding(s) in Company
10th Mar 20207:00 amRNSPreliminary Results
3rd Mar 20204:27 pmRNSFacility Increase
13th Feb 202012:06 pmRNSFourth Quarter Dividend
7th Feb 20207:00 amRNSCompletion of Acquisition
31st Jan 20207:00 amRNSFacility Increase
23rd Jan 20202:00 pmRNSChange of Adviser
23rd Jan 20208:38 amRNSDirector Declaration
16th Jan 20203:51 pmRNSHolding(s) in Company
9th Jan 20205:57 pmRNSHolding(s) in Company
20th Dec 20196:08 pmRNSCompletion of acquisition of office building
19th Dec 20192:55 pmRNSAcquisition of portfolio of six office properties
10th Dec 201910:59 amRNSDirector/PDMR Shareholding
10th Dec 201910:58 amRNSDirector/PDMR Shareholding
10th Dec 201910:57 amRNSDirector/PDMR Shareholding
10th Dec 201910:56 amRNSDirector/PDMR Shareholding
10th Dec 201910:56 amRNSDirector/PDMR Shareholding
10th Dec 201910:54 amRNSDirector/PDMR Shareholding
9th Dec 20192:02 pmRNSHolding(s) in Company
6th Dec 20193:20 pmRNSHolding(s) in Company
6th Dec 20198:00 amRNSEuronext Growth Dublin Notice
4th Dec 20193:42 pmRNSResult of Placing
22nd Nov 20197:00 amRNSProposed Placing
11th Nov 20197:00 amRNSSale of non-core property
1st Nov 20197:00 amRNSIDA Ireland Building Acquisition
26th Sep 20194:39 pmRNSThird Quarter Dividend
4th Sep 20191:50 pmRNSInterim Results
19th Jul 20193:30 pmRNSAcquisition of Portfolio
15th Jul 20194:40 pmRNSDirector/PDMR Shareholding
15th Jul 20194:40 pmRNSDirector/PDMR Shareholding
15th Jul 20194:36 pmRNSDirector/PDMR Shareholding
15th Jul 20194:35 pmRNSDirector/PDMR Shareholding
15th Jul 20194:35 pmRNSDirector/PDMR Shareholding
12th Jul 20198:00 amRNSEuronext Growth Dublin Notice
11th Jul 20195:07 pmRNSRevolving Loan Facility Increase
11th Jul 201912:20 pmRNSResult of EGM and Total Voting Rights
26th Jun 20193:05 pmRNSSecond Quarter Interim Dividend Confirmation
18th Jun 201912:00 pmRNSResult of Placing and Notice of EGM
13th Jun 20197:00 amRNSAnnouncement of Share Issuance Programme
29th May 20193:27 pmRNSLease surrender

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.